Skip to main content
. 2022 Oct 21;12(5):6182–6189. doi: 10.1002/cam4.5350

FIGURE 2.

FIGURE 2

Acceptability Curves for the choice of pembrolizumab plus chemotherapy versus chemotherapy at different WTP thresholds in any PD‐L1 expression group. WTP, willingness‐to‐pay.